Key Takeaways
- Revenue miss, unqualified apology: Standalone revenue reached ₹430 crores, falling roughly 5% short of the ₹450 crore guidance due to Chennai floods and supply chain disruptions, now resolved.
- Bold FY25 target set: Management aims to exceed ₹900 crores in revenue, a ~109% YoY jump, backed by a ₹1,200-1,300 crore order inflow target and a high-probability pipeline of ₹900 crores.
- Margin structure resetting: Raw material costs are normalizing at a higher 35-40% of revenue due to product mix and scale, while management commits to 35% EBITDA and 25% PAT margins for FY25.
- Export pivot underway: Exports, which carry better margins, are targeted to contribute 30-35% of FY25 revenue, with significant figures expected in forthcoming quarters after a nil Q4.
- What to watch next quarter: Whether the promised order inflow begins in Q2, the pace of inventory conversion into revenue, and any concrete announcements on the teased "path-breaking" new products.
The Revenue Miss & Working Capital Build
- Shortfall drivers: Chennai floods disrupted the supply chain, alongside other resolved issues, causing the company to miss its ₹450 crore standalone guidance. Management offered an unqualified apology for the miss.
- Inventory surge: Inventory jumped 224% from ₹41 crores to ₹133 crores, a deliberate build to support execution against the current year's budgeted targets. This drove the working capital cycle to 148 days, within the guided 130-150 day range.
- Receivables stretch: Receivable days hit 143, pushed higher by a concentration of sales in Q4. The working capital cycle is expected to stay in a 140 to 160 day range going forward.
- No export contribution: All Q4 sales were domestic, with no export revenue recorded, underscoring the lumpiness the company acknowledges in quarterly export flows.
Ashok Atluri: "I have nothing to say but I may offer an unqualified apology. We shouldn't have fallen short but we made our best attempt but we couldn't reach."
FY25 Growth Ambition & Order Book Dynamics
- Revenue target: The company aims to exceed ₹900 crores in FY25, more than doubling from the FY24 base, and maintains a FY27 target of ₹2,000 crores, implying a 50% CAGR.
- Order replenishment math: To sustain this growth, management targets ₹1,200 to ₹1,300 crores in new order inflows, a replenishment rate exceeding 33% of the revenue target. This target covers existing products only; any new product orders would be additive.
- Pipeline visibility: A high-probability order pipeline of roughly ₹900 crores is already being worked, with very large projects at the drawing board stage carrying good probability.
- Execution speed as a double-edged sword: The company executes orders in 12-18 months versus the industry-typical 3 years, which means it exhausts its order book quickly and cannot show long-dated visibility without deliberately slowing down, a trade-off management refuses to make.
- Order inflow timing: The majority of orders are expected to start in Q3 and Q4, with smaller orders potentially beginning in Q2. This back-end loading creates a risk to the FY25 target if delays occur.
Margin Profile & Cost Structure Reset
- Gross margin pressure: Gross margins were impacted by a spike in raw material costs for certain products. Contracts are fixed-price with no pass-through mechanism, as metal costs are not significant enough to warrant escalation clauses in government and army contracts.
- Raw material normalization: Material cost as a percentage of revenue rose to 33.3%, up from a 20-26% historical trend. Management attributes this to product mix, the scale of operations, and AMC revenue not growing proportionately with equipment sales. The new normal is guided at 35% to 40%.
- Profitability commitment: Despite the cost reset, management commits to 35% EBITDA and 25% PAT margins for FY25. By segment, simulators carry ~40% EBITDA margins while anti-drone systems carry ~30%.
- Export margin premium: Exports deliver better margins than domestic sales, making the targeted 30-35% export mix a margin tailwind if achieved.
Ashok Atluri: "I really want to temper those expectations. Especially, given the vast product mix that we have and especially for highly commercial, dual use commercial simulators, we have the cost of production as a little higher than the regular ones."
Export Opportunity & Competitive Position
- Export ambition: Out of the ₹900 crore FY25 target, at least 30-33% is earmarked for exports, with management promising significant export figures in forthcoming quarters after a nil Q4.
- Middle East traction: Participation in a Middle East exhibition generated robust demand and requests for collaboration and product development, validating the international appetite for Zen's training equipment and anti-drone systems.
- Competitive edge: Domestically, DRDO transfers technology to multiple companies, but management asserts Zen is more nimble, adds features faster, and is product-to-product more advanced than competition. The company expects to win a good number of orders both domestically and in exports.
- Anti-drone demand: Management sees huge demand for anti-drone systems both domestically and internationally, expecting that segment to scale up significantly. The company has tested and successfully neutralized so-called undetectable drones.
Ashok Atluri: "So keeping these two things, the preparedness and the emerging threat. Both the solutions are available with Zen Technologies, so we are at a very, very sweet spot and we expect a lot of inquiries as we are dealing, a lot of inquiries coming in, we can feel it and we think that there will be tremendous growth in the export area from both these fronts."
Product Pipeline & Strategic Investments
- New products teased: Management promises to announce "quite path breaking" new products in the coming weeks and months, pending completion of formalities. These will either enhance existing products or target adjacent markets, with any resulting orders treated as upside to the ₹1,200-1,300 crore inflow target.
- AI Turing investment rationale: The investment in AI Turing was made to secure a critical camera solution for the anti-drone system after other suppliers struggled to deliver. The move protects Zen's ability to offer a complete anti-drone product.
- OEM tie-ups in progress: Some OEM tie-ups have been arranged but not yet signed; announcements will follow once documents are finalized.
- Inorganic growth capacity: The company has permission to raise up to ₹1,000 crores via QIP for acquisitions, though no target has been identified yet. Management is looking at acquisitions to gain both market access and technology.
- Medical devices sidelined: The medical devices subsidiary saw no activity in the past year and the business does not look promising at this point, with no activity foreseen in the near future.
Ashok Atluri: "this cat and mouse game keeps going on, one upmanship keeps going on this"
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue target | Exceed ₹900 crores in standalone revenue | FY25 |
| Profitability | 35% EBITDA and 25% PAT margins | FY25 |
| Export mix | Exports to contribute 30-35% of revenue | FY25 |
| Order inflow | ₹1,200 to ₹1,300 crores in new orders, from existing products only | FY25 (majority in Q3/Q4) |
| Working capital cycle | Maintain within 140 to 160 days | Ongoing |
| Raw material cost | Normalize at 35% to 40% of revenue | Ongoing |
| R&D spend | Approximately ₹30 crores, with opportunistic upside | FY25 |
| FY27 revenue target | ₹2,000 crores, a 50% CAGR from FY25 | FY27 |
Key Metrics
| Metric | Q4 FY24 |
|---|---|
| Revenue (standalone) | ₹430 cr, +167% YoY; fell short of ₹450 cr guidance by ~5% |
| Q4 FY24 revenue | ₹136 cr, up 167% YoY |
| EBITDA margin guidance | 35%, expected to be sustainable in FY25 |
| PAT margin guidance | 25%, expected to be sustainable in FY25 |
| Order book | ₹1,400+ cr as of 31st March, including ₹400+ cr for exports |
| Order wins (FY24) | ₹1,350 cr, a record year for order inflows |
| FY25 revenue target | ₹900+ cr, based on existing order book |
| FY27 revenue target | ₹2,000 cr, implying a 50% CAGR from FY25 |
| Export contribution target | ~35% of revenue going forward |
| Working capital cycle | 148 days, expected to remain in the 140–160 day range |
| Receivable days | 143 days, driven by higher Q4 sales; absolute receivables at ₹169 cr |
| Inventory days | 113 days, inventory rose to ₹133 cr from ₹41 cr to support execution |
| Advance from customers | 146 days, included in other current liabilities |
| R&D spend (FY25 plan) | ~₹30 cr, opportunistic investments may increase this |
| Order inflow target (FY25) | ₹1,200–1,300 cr, expected to materialize from Q3 and Q4 |
| High-probability order pipeline | ~₹900 cr, in addition to the existing order book |
| Raw material cost range (going forward) | 35%–40% of revenue, up from 25%–27% trend due to product mix and scale |
| Simulator EBITDA margin | ~40% on average |
| Anti-drone EBITDA margin | ~30% on average |
| Insurance claim received | ₹4.4 cr, against original claim of ₹6.56 cr; balance ₹2.16 cr written off earlier |
| QIP enabling resolution | Up to ₹1,000 cr, no target identified yet |